AVANIR PHARMACEUTICALS, INC CL A
AVNR
AVNR was delisted on the 12th of January, 2015.
108 hedge funds and large institutions have $449M invested in AVANIR PHARMACEUTICALS, INC CL A in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 22 reducing their positions, and 12 closing their positions.
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
114% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 22
14% more funds holding
Funds holding: 95 → 108 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $473M → $449M (-$23.6M)
36% less call options, than puts
Call options by funds: $3.87M | Put options by funds: $6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$10.8M |
| 2 |
O
OrbiMed
New York
|
+$8.83M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$6.78M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
+$4.64M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$4.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$24.7M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.16M |
| 3 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$4.13M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.32M |
| 5 |
Barclays
London,
United Kingdom
|
-$2.59M |
AVNR Hedge Fund Activity: Q3 2013 in Review
108 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q3 2013, worth a combined $449M — down 5% from $473M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new AVNR positions and 12 closed out — a net gain of 14 holders — while 47 added to existing stakes and 22 trimmed.
The largest buyer was State Street, adding an estimated $10.8M. The largest seller was Wellington Management Group, cutting an estimated $24.7M.
- 108 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q3 2013, up from 95 in Q2 2013.
- Funds reported $449M of AVANIR PHARMACEUTICALS, INC CL A stock for Q3 2013, down 5% quarter-over-quarter.
- 26 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q3 2013 and 12 closed out, a net change of +14 holders.
- The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q3 2013 was State Street, an estimated $10.8M added.
- The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q3 2013 was Wellington Management Group, an estimated $24.7M sold.
Based on aggregated 13F filings for Q3 2013.